Viewing Study NCT06190067


Ignite Creation Date: 2025-12-25 @ 12:34 AM
Ignite Modification Date: 2026-01-04 @ 10:28 AM
Study NCT ID: NCT06190067
Status: RECRUITING
Last Update Posted: 2024-01-30
First Post: 2023-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma
Sponsor: Navy General Hospital, Beijing
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module